Loss of immune tolerance to IL-2 in type 1 diabetes
Type 1 diabetes is driven by T-cell autoimmunity to pancreatic islet cells. Here the authors show that autoreactive anti-IL-2 T and B cells are present in type 1 diabetes patients, and that anti-IL-2 antibodies precede diabetes onset in mice, suggesting their potential as a diagnostic marker.
Guardado en:
Autores principales: | Louis Pérol, John M. Lindner, Pamela Caudana, Nicolas Gonzalo Nunez, Audrey Baeyens, Andrea Valle, Christine Sedlik, Delphine Loirat, Olivier Boyer, Alain Créange, José Laurent Cohen, Ute Christine Rogner, Jun Yamanouchi, Martine Marchant, Xavier Charles Leber, Meike Scharenberg, Marie-Claude Gagnerault, Roberto Mallone, Manuela Battaglia, Pere Santamaria, Agnès Hartemann, Elisabetta Traggiai, Eliane Piaggio |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/db770a8739b84dbf870ffd96cace147e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients
por: Nicolas Gonzalo Núñez, et al.
Publicado: (2020) -
Induction of anergic or regulatory tumor-specific CD4+ T cells in the tumor-draining lymph node
por: Ruby Alonso, et al.
Publicado: (2018) -
Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines
por: Channakeshava Sokke Umeshappa, et al.
Publicado: (2019) -
Increased yields and biological potency of knob-into-hole-based soluble MHC class II molecules
por: Pau Serra, et al.
Publicado: (2019) -
EVALUACIÓN DE LA INTEGRACIÓN URBANO-TERRITORIAL EN COLOMBIA
por: Jiménez-Romera,Carlos, et al.
Publicado: (2021)